{
  "docId": "019de070-e903-74a9-9f33-ed76332a0b3c",
  "docSlug": "2d6e5497feb9d00bbad6c284998b10c3",
  "documentTitle": "MindMed | Investor Presentation Deck | 33 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 33,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "Includes a timeline visualization and a map indicating trial locations.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-e903-74a9-9f33-ed76332a0b3c/13",
  "deckHref": "/decks/019de070-e903-74a9-9f33-ed76332a0b3c",
  "deckJsonHref": "/decks/019de070-e903-74a9-9f33-ed76332a0b3c.json",
  "deckAnchorHref": "/decks/019de070-e903-74a9-9f33-ed76332a0b3c#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.76,
        "x": 0.12,
        "y": 0.35
      },
      "kind": "diagram",
      "text": "Timeline showing Phase 1A through Approval, with Phase 2A highlighted.",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "116a1d9a-c476-44ea-9630-d147e24892b3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.04,
        "x": 0.45,
        "y": 0.29
      },
      "kind": "image",
      "text": "Dr. Kim Kuypers",
      "attrs": null,
      "subkind": "headshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2b20a6e6-1112-4d3f-9fe2-9689bf45a35a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.04,
        "x": 0.5,
        "y": 0.29
      },
      "kind": "image",
      "text": "Dr. Matthias Liechti",
      "attrs": null,
      "subkind": "headshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c91d86cf-369f-4361-96c4-b2890ee7c5a6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.78,
        "y": 0.58
      },
      "kind": "image",
      "text": "World map highlighting Europe",
      "attrs": null,
      "subkind": "map",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "989f7984-8a16-44c3-b1c3-8809c03605a9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.35,
        "x": 0.53,
        "y": 0.57
      },
      "kind": "list",
      "text": "Clinical Trial Progress and Details: Phase 2a anticipated to begin in Q3 2021 in Europe, Low dose LSD (20 mcg) compared with a placebo administered for 6 weeks. Locations: Maastricht (Netherlands)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0c5e4eb6-af3a-4d3e-a798-0eebb2b74810",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.35,
        "x": 0.1,
        "y": 0.57
      },
      "kind": "list",
      "text": "Extensive anecdotal evidence suggests microdosing Psilocybin & LSD may: Increase focus, Decrease anxiety, Increase creativity, Improve mood",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2272c623-7d08-4f2b-9318-81a8e45bb23c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.45,
        "x": 0.048,
        "y": 0.11
      },
      "kind": "paragraph",
      "text": "Proof of Concept Using Sub-perceptual Amounts of LSD (Microdose)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9d2c234f-3f56-4e47-adf2-2ab0b78097fb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.45,
        "x": 0.09,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "*Management estimates; actual timeline will depend on results, approvals and other factors outside of MindMed's control",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aae686f9-8e3d-4c8b-ae4d-de7531cbd2ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.048,
        "y": 0.056
      },
      "kind": "title",
      "text": "Develop: LSD Microdosing Phase 2a Clinical Trial",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8a5c16b0-6be3-4537-a617-546fc55d29c7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "a0e1e80f-0bca-40ae-aa6d-d72e090ec013",
      "evidence": "Visual representation of clinical trial phases over time.",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}